<?xml version="1.0" encoding="UTF-8"?>
<p>Presently, consensus guidelines on the treatment of Kounis syndrome are lacking. Many effective treatments are derived from case reports. H1 antihistamines, H2 antihistamines and corticosteroids are widely used to inhibit allergic reactions (
 <xref rid="B13" ref-type="bibr">13</xref>). Although epinephrine is a commonly used first-line drug to treat allergic reactions, it may aggravate coronary artery spasm and should be used with caution (
 <xref rid="B14" ref-type="bibr">14</xref>). Vasodilators, such as nitrates and calcium channel blockers, can relieve allergic vasospasms. The treatment of Kounis types II and III should also follow the latest guidelines for acute coronary syndrome (
 <xref rid="B15" ref-type="bibr">15</xref>, 
 <xref rid="B16" ref-type="bibr">16</xref>).
</p>
